✦ LIBER ✦

Double-blind studies in severe Alzheimer's disease

✍ Scribed by B. Vellas

Book ID: 119575201
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 148 KB
Volume: 11
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(01)80093-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donepezil in patients with severe Alzhei

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study

✍ Bengt Winblad; Lena Kilander; Sture Eriksson; Lennart Minthon; Stellan Båtsman; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 169 KB

Risperidone and rivastigmine and agitate

Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study

✍ Clive Holmes; David Wilkinson; Christine Dean; Corinne Clare; Mohammed El-Okl; C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

Safety and efficacy of galantamine (Remi

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

✍ Alistair Burns; Roberto Bernabei; Roger Bullock; Alfonso J Cruz Jentoft; Lutz Fr 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 226 KB

Safety and tolerability of once-daily ve

Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease

✍ Roy W. Jones; Antony Bayer; Fraser Inglis; Andrew Barker; Ravinder Phul 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Objective To assess the safety and tolerability of three different dosing schedules of memantine in patients with moderate to severe Alzheimer's disease (AD). ## Method This 12‐week, randomised, double‐blind study, investigated three dosing schedules of memantine: OD1 (20 mg once

P4-337: Dimebon improves cognition, func

P4-337: Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study

✍ Doody, Rachelle S.; Gavrilova, Svetlana; Thomas, Ronald; Aisen, Paul; Bachurin, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Effectiveness and tolerability of high-d

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study

✍ Martin R. Farlow; Stephen Salloway; Pierre N. Tariot; Jane Yardley; Margaret L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB